No Data
No Data
Lake Street Starts Myomo With Buy Rating, $7 Price Target
Myomo (MYO) has an average rating of buy and price targets ranging from $5.25 to $8.25, according to analysts polled by Capital IQ.
Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO)
Myomo(MYO.US) Officer Sells US$130.84K in Common Stock
$Myomo(MYO.US)$ Officer Kovelman Harry sold 35,426 shares of common stock on May 15, 2024 at an average price of $3.6933 for a total value of $130.84K.Source: Announcement What is statement of changes
Form 144 | Myomo(MYO.US) Officer Proposes to Sell 130.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Myomo(MYO.US)$ Officer HARRY KOVELMAN intends to sell 35,426 shares of its common stock on May 15, with a total market value of approximately $130.84K. HARRY KOVELMA
Myomo Inc Reports Q1 2024 Earnings: Revenue Up Despite Challenges
Myomo's Strategic Turnaround: A Buy Rating With Revenue Growth and Operational Scaling on the Horizon
No Data